Our previous studies indicate that oxycodone is a putative k-opioid agonist, whereas morphine is a well documented m-opioid agonist. Because there is limited information regard-ing the development of tolerance to oxycodone, this study was designed to 1) document the development of tolerance to the antinociceptive effects of chronically infused i.v. oxycodone relative to that for i.v. morphine and 2) quantify the degree of antinociceptive cross-tolerance between morphine and oxyc-odone in adult male Dark Agouti (DA) rats. Antinociceptive testing was performed using the tail-flick latency test. Com-plete antinociceptive tolerance was achieved in 48 to 84 h after chronic infusion of equi-antinociceptive doses of i.v. oxyc-odone (2.5 mg/24 h an...
Our previous studies in the Sprague-Dawley rat showed that the intrinsic antinociceptive effects of ...
Key-press responding of mice was maintained under a fixed-ratio (FR) 30-response schedule of food pr...
The irreversible cholinesterase inhibitor diisopropylphosphofluoridate (DFP) causes a naloxone-sensi...
Our previous studies indicate that oxycodone is a putative kappa-opioid agonist, whereas morphine is...
ABSTRACT Our previous studies indicate that oxycodone is a putative -opioid agonist, whereas morphin...
Oxycodone and morphine are structurally related, strong opioid analgesics, commonly used to treat mo...
Development of antinociceptive tolerance in the clinic after repeated administration of morphine lim...
Oxycodone and morphine are two opioid drugs commonly used for the treatment of moderate to severe pa...
Systemic administration of morphine typically produces greater tolerance than higher efficacy mu-opi...
Tolerance to the antinociceptive effect of mu-opioid receptor (MOPr) agonists, such as morphine and ...
Development of tolerance and cross-tolerance after acute administration of the μ agonist morphine an...
Antinociceptive tolerance after repetitive administration of morphine severely limits its clinical u...
Opioids remain the drugs of choice in chronic pain treatment, but opioid tolerance, defined as a dec...
Background: Ketamine attenuates morphine tolerance by antagonising N-methyl-D-aspartate receptors. H...
The development of cross-tolerance to an analgesic effect was observed between two mu-receptor agoni...
Our previous studies in the Sprague-Dawley rat showed that the intrinsic antinociceptive effects of ...
Key-press responding of mice was maintained under a fixed-ratio (FR) 30-response schedule of food pr...
The irreversible cholinesterase inhibitor diisopropylphosphofluoridate (DFP) causes a naloxone-sensi...
Our previous studies indicate that oxycodone is a putative kappa-opioid agonist, whereas morphine is...
ABSTRACT Our previous studies indicate that oxycodone is a putative -opioid agonist, whereas morphin...
Oxycodone and morphine are structurally related, strong opioid analgesics, commonly used to treat mo...
Development of antinociceptive tolerance in the clinic after repeated administration of morphine lim...
Oxycodone and morphine are two opioid drugs commonly used for the treatment of moderate to severe pa...
Systemic administration of morphine typically produces greater tolerance than higher efficacy mu-opi...
Tolerance to the antinociceptive effect of mu-opioid receptor (MOPr) agonists, such as morphine and ...
Development of tolerance and cross-tolerance after acute administration of the μ agonist morphine an...
Antinociceptive tolerance after repetitive administration of morphine severely limits its clinical u...
Opioids remain the drugs of choice in chronic pain treatment, but opioid tolerance, defined as a dec...
Background: Ketamine attenuates morphine tolerance by antagonising N-methyl-D-aspartate receptors. H...
The development of cross-tolerance to an analgesic effect was observed between two mu-receptor agoni...
Our previous studies in the Sprague-Dawley rat showed that the intrinsic antinociceptive effects of ...
Key-press responding of mice was maintained under a fixed-ratio (FR) 30-response schedule of food pr...
The irreversible cholinesterase inhibitor diisopropylphosphofluoridate (DFP) causes a naloxone-sensi...